Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates

Related NEOG
Earnings Scheduled For December 18, 2014
Ebola Vaccine Contenders
Related ABAX
Is Abaxis Worth Adding To Your Investment Portfolio?
Chimerix, Inc. (CMRX) in Focus: Stock Up 5.6%

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year.

Neogen (NASDAQ: NEOG) is likely to earn $1.30 per share in the next year ending May, 2014. Neogen's PEG ratio is 2.06.

Abaxis (NASDAQ: ABAX) may earn $1.11 per share in the next year ending March, 2014. Abaxis' trailing-twelve-month operating margin is 12.95%.

Trinity Biotech plc (NASDAQ: TRIB) is projected to earn $0.92 per share for the next year ending December, 2013. Trinity Biotech's trailing-twelve-month revenue is $80.67 million.

Meridian Bioscience (NASDAQ: VIVO) is expected to earn $0.88 per share over the next year ending September, 2013. Meridian Bioscience's trailing-twelve-month ROE is 22.58%.

Posted-In: Diagnostic Substances Industry Highest EPS Estimates small-capTrading Ideas

 

Related Articles (ABAX + NEOG)

Around the Web, We're Loving...

Get Benzinga's Newsletters